Bifidumbacterin forte, 50 mln. coe/package 10 pcs

Pharmacotherapeutic group

Medical immunobiological drug – probiotic

ATX code A07FA

Biological properties
The action of the drug is conditioned by high concentration of bifidobacteria (Bifidobacterium bifidum) adsorbed on activated charcoal particles which are antagonists of a wide range of pathogenic (Shigella, Salmonella, Staphylococcus aureus etc.) and conditionally pathogenic bifidobacteria.) and conditionally pathogenic microorganisms (Proteus, Klebsiella, etc.). Microcolonies of sorbed bifidobacteria provide rapid recovery of normal microflora, which, as a natural biosorbent, accumulates a significant amount of foreign or formed in the body toxic substances. Sorbed bifidobacteria activate regenerative processes in mucous membranes, wall-to-wall digestion, synthesis of vitamins and amino acids, enhance immune defense.

Indications

Diarrhea, Intestinal infections, Vaginitis, Bloating, Colitis, Allergy, Dysbacteriosis, Inflammation of the female reproductive organs

• Dysbacteriosis of the intestines of various etiologies (including those caused by taking antibiotics, antibacterial drugs, glucocorticosteroid hormones, drugs that have a gastrointestinal carcinogenic effect. Caused by taking antibiotics, antibacterial drugs, glucocorticosteroid hormones, drugs that have a ulcerogenic effect on the gastrointestinal tract),
• food toxic infections.

In the treatment of diseases accompanied by intestinal dysbacteriosis:

• chronic diseases with lesions of the gastrointestinal tract (gastric and duodenal ulcer, pancreatitis, cholecystitis, liver and biliary tract diseases, chronic constipation, malabsorption syndrome),
• allergic diseases,
• pneumonia, acute and chronic bronchitis,
• acute respiratory viral infections,
• infectious mononucleosis,
• inflammatory diseases of the urogenital tract,
• in surgical patients during pre-operative preparation and after operations on the intestine, liver, pancreas for correction of intestinal microbiocenosis and prevention of septic-inflammatory diseases.

The drug is used for the prevention of:

• internal hospital infections in maternity homes and hospitals,
• dysbacteriosis in children and adults who are often ill with ARI.

.

Active ingredient

Bifidobacterium bifidum

Composition

Active substance – bifidobacteria sorbed on activated charcoal particles – at least 50 million colony forming units (5×107 CFU),
supplement – lactose monohydrate – up to 0.85 g.

.

How to take, the dosage

The drug is used from birth (including premature babies), adults of all age groups.

Depending on the severity of the disease Bifidumbacterin forte® is used in regular or increased doses.

Bifidumbacterin forte® for therapeutic purposes in normal doses:

• children under 1 year old 1 bag 2-3 times a day,
• children from 1 year and older 1 bag 3-4 times a day,
• adults 2 bags 2-3 times a day.

Course of treatment for acute intestinal infections and food toxic infections 5-

7 days, with other diseases 15-21 days (determined by the nature and severity of the disease). If necessary, the course of treatment may be repeated 2-3 times, each course is carried out one month after the end of the previous course of treatment.

Patients with surgical pathology – for 3-5 days before surgery and for 10-15 days after surgery:

• children under 1 year old 1 bag 3 times a day,
• children from 1 year and older 1 bag 3-4 times a day,
• adults 2 bags 3 times a day.

Bifidumbacterin forte® with therapeutic purposes in increased doses is indicated for children from 1 year and adults.

In acute intestinal infection and acute respiratory viral infection from the first day of the disease:

• children 5 bags 6 times a day,
• adults 10 bags 3 times a day.

Course of treatment 1-3 days depending on the severity of the condition.

Infectious mononucleosis:

• Children under 3 years old take 3 bags 3 times a day, course of 5 days; then 3 bags once in the evening, course of 5 days,
• children 3 to 7 years old take 4 bags 3 times a day, course of 5 days; then 4 bags once in the evening, course of 5 days,<
• Children from 7 to 10 years: 6 packets 3 times a day, course of 5 days; then 6 packets once in the evening, course of 5 days,
• Children over 10 years: 7-8 packets 3 times a day, course of 5 days; then 7-8 packets once in the evening, course of 5 days.

Chronic diseases of the gastrointestinal tract:

• children 5 bags 1-3 times a day,
• adults 10 bags 1-3 times a day. The course of treatment is 10-14 days.

Patients with diabetes need to know that 5 pouches of the drug contain 0.35 IU.

For preventive purposes, children under 1 year old take 1 pouch once a day, for all others 1-2 pouches 1-2 times a day. The prophylactic course is 10-15 days, 2-3 times a year.

Bifidumbacterin forte® is taken with meals, if necessary, regardless of meals. Before using the drug is mixed with liquid food, preferably fermented milk products, or a small amount of boiled water at room temperature in order to obtain a suspension with black sorbent particles. The resulting suspension should be drunk without achieving complete dissolution. Newborns and infants can mix the drug with mother’s milk or formula for artificial feeding.

Interaction

Simultaneous administration of Bifidumbacterin forte® with vitamins (especially B group) increases the effect of the drug. When taking antibiotics, the recommended interval between taking antibiotics and Bifidumbacterin forte® is 3 – 4 hours.

Special Instructions

The drug does not affect the ability to drive vehicles and mechanisms.

Synopsis

Powder from light gray to dark gray in color with black charcoal particles and possible inclusions of beige color with a faint sour milk odor.

Contraindications

Congenital lactase deficiency. Impaired glucose-galactose absorption.

Side effects

Not established.

Overdose

No cases of overdose were observed.

Pregnancy use

The drug is approved for use in women during pregnancy and breastfeeding. There are no special conditions for use.

Similarities

Bifidumbacterin